ARDSLEY ADVISORY PARTNERS LP 13D and 13G filings for Aspire Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-13 1:00 pm Sale | 2025-12-31 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | ARDSLEY ADVISORY PARTNERS LP | 0 0.000% | -10,750,000 (Position Closed) | Filing |
| 2026-02-12 1:00 pm Purchase | 2025-12-31 | 13G | ASPIRE BIOPHARMA HLDGS INC ASBP | ARDSLEY ADVISORY PARTNERS LP | 358,333 7.760% | 358,333 (New Position) | Filing |